HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.

Abstract
These studies were designed to investigate the protective effects of the new angiotensin II receptors antagonist BAY 10-6734 (6-n-butyl-4-methoxycarbonyl-2-oxo-1[(2'-(1H-tetrazol-5-yl) -3-fluorobiphenyl-4-yl)methyl] 1,2-dihydropyridine, CAS 156001-18-2) on haemodynamic, hormonal, renal, and structural parameters in renin transgenic rats (TGR(mRen2)27), salt-loaded Dahl S and R rats, and salt-loaded stroke-prone spontaneously hypertensive rats (SHR-SP) in long-term trials. Study 1: In SHR-SP the development of blood pressure, cardiac hypertrophy, and the deleterious effects of salt loading on kidney structure and kidney function was prevented by BAY 10-6734. Study 2: In salt-loaded Dahl S rats with a suppressed plasma renin activity treatment with BAY 10-6734 did not delay the increase in blood pressure but prevented cardiac hypertrophy and the increase in plasma ANP (Atrial natriuretic peptide). Study 3: TGR develop malignant hypertension associated with cardiac hypertrophy, elevated left-ventricular end-diastolic pressure and increased plasma ANP. After 6 weeks of treatment with BAY 10-6734 (30 mg/kg p.o. bid) cardiac pump function was improved and cardiac hypertrophy was reversed in this angiotension dependent form of hypertension. The beneficial effects of BAY 10-6734 in these different animal hypertension models are also emphasized by a reduction in mortality.
AuthorsJ P Stasch, A Knorr, C Hirth-Dietrich, T Krämer, W Hübsch, J Dressel, P Fey, M Beuck, E Sander, K Frobel, S Kazda
JournalArzneimittel-Forschung (Arzneimittelforschung) Vol. 47 Issue 9 Pg. 1016-23 (Sep 1997) ISSN: 0004-4172 [Print] Germany
PMID9342414 (Publication Type: Journal Article)
Chemical References
  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Dihydropyridines
  • Hormones
  • Tetrazoles
  • Angiotensin II
  • Aldosterone
  • embusartan
  • Atrial Natriuretic Factor
  • Renin
  • Cyclic GMP
Topics
  • Aldosterone (blood)
  • Angiotensin II (metabolism)
  • Angiotensin Receptor Antagonists
  • Animals
  • Animals, Genetically Modified
  • Antihypertensive Agents (pharmacology)
  • Atrial Natriuretic Factor (blood)
  • Body Weight (drug effects)
  • Cerebrovascular Disorders (genetics, physiopathology)
  • Cyclic GMP (blood)
  • Dihydropyridines (pharmacology)
  • Hemodynamics (drug effects)
  • Hormones (blood)
  • Hypertension (chemically induced, genetics, prevention & control)
  • Kidney (pathology, physiopathology)
  • Rats
  • Rats, Inbred SHR
  • Renin (genetics)
  • Tetrazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: